Abstract:Promoting endogenous neurogenesis for brain repair is emerging as a promising strategy to mitigate the functional impairments associated with various neurological disorders characterized by neuronal death. Diterpenes featuring tigliane, ingenane, jatrophane and lathyrane skeletons, frequently found in Euphorbia plant species, are known protein kinase C (PKC) activators and exhibit a wide variety of pharmacological properties, including the stimulation of neurogenesis. Microbial transformation of these diterpenes represents a green and sustainable methodology that offers a hitherto little explored approach to obtaining novel derivatives and exploring structure-activity relationships. In the present study, we report the biotransformation of euphoboetirane A (4) and epoxyboetirane A (5), two lathyrane diterpenoids isolated from Euphorbia boetica, by Mucor circinelloides MC NRRL3631. Our findings revealed the production of nine biotransformation products (6-14), including jatrophane derivatives originated through an unprecedented rearrangement from the parent lathyranes. The chemical structures and absolute configurations of the new compounds were elucidated through comprehensive analysis using NMR and ECD spectroscopy, as well as MS. The study evaluated how principal metabolites and their derivatives affect TGFα and NRG1 release, as well as their potential to promote proliferation or differentiation in cultures of NSC isolated from the SVZ of adult mice. In order to shed some light on the mechanisms underlying the ability of 12 as a neurogenic compound, the interactions of selected compounds with PKC δ-C1B were analyzed through molecular docking and molecular dynamics. Based on these, it clearly appears that the ability of compound 12 to form both acceptor and donor hydrogen bonds with certain amino acid residues in the enzyme pocket leads to a higher affinity compound-PKC complex, which correlates with the observed biological activity.

Structural Optimization and Neurotrophic Activity Evaluation of Neurotrophic Gentiside Derivatives.

Tetradecyl 2,3-Dihydroxybenzoate Promotes Functional Recovery after Spinal Cord Injury in Adult Rats

Synthesis and Neuroprotective Biological Evaluation of Quinazolinone Derivatives Via Scaffold Hopping.

Synthesis and SAR Studies of Neuritogenic Gentiside Derivatives.

Structure-activity relationships of neuritogenic gentiside derivatives.

Gentisides C–K: Nine New Neuritogenic Compounds from the Traditional Chinese Medicine Gentiana Rigescens Franch

Synthesis and biological evaluation of novel 4-azaindolyl-indolyl-maleimides as glycogen synthase kinase-3β (GSK-3β) inhibitors

Synthesis, biological activity evaluation and mechanism analysis of new ganglioside GM3 derivatives as potential agents for nervous functional recovery

Gentisides A and B, two new neuritogenic compounds from the traditional Chinese medicine Gentiana rigescens Franch.

FK506-binding protein ligands: structure-based design, synthesis, and neurotrophic/neuroprotective properties of substituted 5,5-dimethyl-2-(4-thiazolidine)carboxylates.

Synthesis and Biological Evaluation of Novel 4,5-Bisindolyl-1,2,4-triazol-3-ones As Glycogen Synthase Kinase-3Β Inhibitors and Neuroprotective Agents.

Synthesis and Biological Evaluation of 3-Carbamate Smilagenin Derivatives As Potential Neuroprotective Agents.

Effect of lathyrane-type diterpenoids in neural stem cell physiology: Microbial transformations, molecular docking and dynamics studies

Structure-activity relationship studies of (E)-3,4-dihydroxystyryl alkyl sulfones as novel neuroprotective agents based on improved antioxidant, anti-inflammatory activities and BBB permeability.

Design, Synthesis and Neurite Outgrowth Activity of Novel Ganglioside GM1 Derivatives by Remodeling of the Fatty Acid Moiety

Design, Synthesis and Biological Evaluation of Novel (e)‐hydroxystyryl Aralkyl Sulfones As Neuroprotective Agents

Structural Optimization and Biological Evaluation of Substituted Bisphenol A Derivatives As Beta-Amyloid Peptide Aggregation Inhibitors.

Modeling and Synthesis of Non-Cyclic Derivatives of GPI-1046 As Potential FKBP Ligands with Neurotrophic Properties

Design, Synthesis, and Biological Evaluation of Compounds with a New Scaffold As Anti-Neuroinflammatory Agents for the Treatment of Alzheimer's Disease

Neuritogenic Activity of Tetradecyl 2,3-Dihydroxybenzoate is Mediated Through the Insulin-Like Growth Factor 1 Receptor/Phosphatidylinositol 3 Kinase/Mitogen-Activated Protein Kinase Signaling Pathway

Structural Diversity of Neuritogenic Substances and Their Application Perspective